← Evidence map

ArticleMedical oncology (Northwood, London, England)2026

Narciclasine reduces proliferation and migration of neuroblastoma cells and decreases FAK/PI3K pathway activation.

Ceren Oy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42667307